Supplemental material
Human Vaccines & Immunotherapeutics
Volume 20, 2024 - Issue 1
Influenza
No immunological interference or concerns about safety when seasonal quadrivalent influenza vaccine is co-administered with a COVID-19 mRNA-1273 booster vaccine in adults: A randomized trial
Abdi Naficya GSK, Rockville, MD, USACorrespondence[email protected]
https://orcid.org/0000-0002-1076-5280View further author information
https://orcid.org/0000-0002-1076-5280View further author information, Adrienne Kuxhausena GSK, Rockville, MD, USAhttps://orcid.org/0000-0002-7663-7409View further author information
https://orcid.org/0000-0002-7663-7409View further author information, Harry Seiferta GSK, Rockville, MD, USAhttps://orcid.org/0000-0001-8048-5885View further author information
https://orcid.org/0000-0001-8048-5885View further author information, Andrew Hastiea GSK, Rockville, MD, USAhttps://orcid.org/0000-0002-1782-1580View further author information
https://orcid.org/0000-0002-1782-1580View further author information, Brett Leavb Moderna, Inc, Cambridge, MA, USAhttps://orcid.org/0000-0003-0907-0817View further author information
https://orcid.org/0000-0003-0907-0817View further author information, Jacqueline Millerb Moderna, Inc, Cambridge, MA, USAhttps://orcid.org/0000-0002-7083-2182View further author information
https://orcid.org/0000-0002-7083-2182View further author information, Kate Anteyib Moderna, Inc, Cambridge, MA, USAhttps://orcid.org/0000-0001-5027-4753View further author information
https://orcid.org/0000-0001-5027-4753View further author information & Agnes Mwakingwe-Omaria GSK, Rockville, MD, USAhttps://orcid.org/0000-0002-6576-1981View further author information
https://orcid.org/0000-0002-6576-1981View further author information show all